Skip to main content

and
  1. No Access

    Article

    Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

    Whole-exome sequencing (WES) has emerged as a transformative technology for biological discovery, but technical difficulties have so far prevented its widespread clinical use. Here, Eliezer Van Allen and colle...

    Eliezer M Van Allen, Nikhil Wagle, Petar Stojanov, Danielle L Perrin in Nature Medicine (2014)

  2. Article

    Correction: Corrigendum: Comparative analysis of RNA sequencing methods for degraded or low-input samples

    Nat. Methods 10, 623–629 (2013); published online 19 May 2013; corrected after 2 December 2013 In the version of this article initially published, in the Online Methods “RNase H libraries” section, the sentenc...

    **an Adiconis, Diego Borges-Rivera, Rahul Satija, David S DeLuca in Nature Methods (2014)

  3. No Access

    Article

    Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

    Matthew Meyerson and colleagues report whole-exome and whole-genome sequencing of 55 small intestine neuroendocrine tumors. They identify recurrent somatic mutations in CDKN1B, implicating cell cycle dysregulatio...

    Joshua M Francis, Adam Kiezun, Alex H Ramos, Stefano Serra in Nature Genetics (2013)

  4. No Access

    Article

    Comparative analysis of RNA sequencing methods for degraded or low-input samples

    This comparison of five RNA-seq library preparation methods highlights metrics for assessing the suitability of the methods for samples with low amounts of RNA and/or those with low-quality RNA.

    **an Adiconis, Diego Borges-Rivera, Rahul Satija, David S DeLuca in Nature Methods (2013)

  5. No Access

    Article

    Mutational heterogeneity in cancer and the search for new cancer-associated genes

    As the sample size in cancer genome studies increases, the list of genes identified as significantly mutated is likely to include more false positives; here, this problem is identified as stemming largely from...

    Michael S. Lawrence, Petar Stojanov, Paz Polak, Gregory V. Kryukov in Nature (2013)

  6. No Access

    Article

    Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity

    Adam Bass, Gad Getz and colleagues report whole-exome sequencing of 149 esophageal adenocarcinomas (EACs) and whole-genome sequencing of 15 EACs. They identify a mutational signature defined by a high prevalen...

    Austin M Dulak, Petar Stojanov, Shouyong Peng, Michael S Lawrence in Nature Genetics (2013)

  7. No Access

    Article

    Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

    The MuTect algorithm for calling somatic point mutations enables subclonal analysis of the whole-genome or whole-exome sequencing data being generated in large-scale cancer genomics projects.

    Kristian Cibulskis, Michael S Lawrence, Scott L Carter in Nature Biotechnology (2013)

  8. No Access

    Article

    The genetic landscape of high-risk neuroblastoma

    John Maris, Matthew Meyerson, Marco Marra and colleagues report results of a large-scale sequencing study of neuroblastoma. They observe a low median exonic mutation frequency and strikingly few recurrently mu...

    Trevor J Pugh, Olena Morozova, Edward F Attiyeh, Shahab Asgharzadeh in Nature Genetics (2013)

  9. No Access

    Article

    Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

    Medulloblastoma is the most common brain tumour in children; using exome sequencing of tumour samples the authors show that these cancers have low mutation rates and identify 12 significantly mutated genes, am...

    Trevor J. Pugh, Shyamal Dilhan Weeraratne, Tenley C. Archer in Nature (2012)

  10. No Access

    Article

    Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

    Levi Garraway and colleagues report exome sequencing of 112 prostate adenocarcinomas and matched normal tissues. They identify novel recurrent mutations in several genes, including MED12, FOXA1 and SPOP. They fin...

    Christopher E Barbieri, Sylvan C Baca, Michael S Lawrence in Nature Genetics (2012)

  11. No Access

    Article

    Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

    Matthew Meyerson and colleagues report the whole-genome sequencing of primary colorectal tumors and matched adjacent non-tumor tissue from nine individuals with colorectal cancer. They identify a recurrent VTI1A-...

    Adam J Bass, Michael S Lawrence, Lear E Brace, Alex H Ramos, Yotam Drier in Nature Genetics (2011)

  12. Article

    RNA-Seq methods for imperfect samples: development, evaluation and applications

    **an Adiconis, Lin Fan, David DeLuca, Andrey Sivachenko, Nathalie Pochet in Genome Biology (2011)

  13. Article

    RNA-Seq methods for imperfect samples: development, evaluation and applications

    **an Adiconis, Lin Fan, David DeLuca, Andrey Sivachenko, Nathalie Pochet in Genome Biology (2011)

  14. Article

    Open Access

    Initial genome sequencing and analysis of multiple myeloma

    Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38 tumour genomes and their comparison to matched nor...

    Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats, Kristian Cibulskis in Nature (2011)

  15. No Access

    Article

    Genome-scale DNA methylation maps of pluripotent and differentiated cells

    DNA methylation, an important mechanism of epigenetic modification that produces different patterns of gene expression from a single DNA sequence, is vital to normal development and its malfunction can cause c...

    Alexander Meissner, Tarjei S. Mikkelsen, Hongcang Gu, Marius Wernig, Jacob Hanna in Nature (2008)